{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:25:03Z","timestamp":1790623503474,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.semarthrit.2021.03.008","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T01:40:50Z","timestamp":1616031650000},"page":"457-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment"],"prefix":"10.1016","volume":"51","author":[{"given":"Annelies B.","family":"Blanken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Agca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper M.","family":"van Sijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre E.","family":"Voskuyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvo M.","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conny J.","family":"van der Laken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Nurmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.008_bib0001","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/heartjnl-2015-307838","article-title":"Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders","volume":"102","author":"Agca","year":"2016","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.03.008_bib0002","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2008.094151","article-title":"Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation","volume":"68","author":"van Halm","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"10.1016\/j.semarthrit.2021.03.008_bib0003","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \"high-grade\" systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.03.008_bib0004","first-page":"937","article-title":"Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis","volume":"34","author":"Aubry","year":"2007","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.03.008_bib0005","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/rheumatology\/ket454","article-title":"Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?","volume":"53","author":"Tam","year":"2014","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.008_bib0006","first-page":"225","article-title":"Certolizumab pegol attenuates the pro-inflammatory state in endothelial cells in a manner that is atheroprotective","volume":"31","author":"Heathfield","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.03.008_bib0007","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.03.008_bib0008","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.008_bib0009","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00296-009-0935-2","article-title":"Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis","volume":"30","author":"Ferrante","year":"2009","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.03.008_bib0010","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/rheumatology\/kem089","article-title":"Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis","volume":"46","author":"Del Porto","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.03.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/674265","article-title":"Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy","volume":"2012","author":"Gonzalez-Juanatey","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.008_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2012.02.002","article-title":"The effect of tumor necrosis factor-alpha antagonists on arterial stiffness in rheumatoid arthritis: a literature review","volume":"42","author":"Dulai","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.008_bib0013","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s12350-016-0766-y","article-title":"Molecular imaging of atherosclerosis with integrated PET imaging","volume":"24","author":"Hammad","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.03.008_bib0014","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.semarthrit.2021.03.008_bib0015","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/01.CIR.0000020548.60110.76","article-title":"Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography","volume":"105","author":"Rudd","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2021.03.008_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2385-6-3","article-title":"Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation","volume":"6","author":"Zhang","year":"2006","journal-title":"BMC Nucl Med"},{"issue":"14","key":"10.1016\/j.semarthrit.2021.03.008_bib0017","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jacc.2006.11.046","article-title":"Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome","volume":"49","author":"Tahara","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.008_bib0018","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCIMAGING.108.811752","article-title":"Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography\/computed tomography imaging study","volume":"2","author":"Rudd","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.008_bib0019","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/CIRCIMAGING.110.959478","article-title":"Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology","volume":"5","author":"Figueroa","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.03.008_bib0020","first-page":"1245","article-title":"(18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study","volume":"45","author":"Ogawa","year":"2004","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.008_bib0021","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10554-019-01744-0","article-title":"Should vascular wall (18)F-FDG uptake be adjusted for the extent of atherosclerotic burden?","volume":"36","author":"Lensen","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.008_bib0022","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2967\/jnumed.109.065151","article-title":"18F-FDG PET\/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease","volume":"50","author":"Rominger","year":"2009","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.03.008_bib0023","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jcmg.2013.08.006","article-title":"Measurement of arterial activity on routine FDG PET\/CT images improves prediction of risk of future CV events","volume":"6","author":"Figueroa","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.008_bib0024","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nuclcard.2007.10.009","article-title":"Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events","volume":"15","author":"Paulmier","year":"2008","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.008_bib0025","first-page":"273","article-title":"A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET\/CT: a pilot study","volume":"3","author":"Rose","year":"2013","journal-title":"Am J Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.03.008_bib0026","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jcmg.2014.03.018","article-title":"Arterial 18F-FDG uptake in rheumatoid arthritis correlates with synovial activity","volume":"7","author":"Emami","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.008_bib0027","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41598-017-00989-w","article-title":"Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation","volume":"7","author":"Skeoch","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.008_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.40345","article-title":"Arterial inflammation detected with (18) F-fluorodeoxyglucose-positron emission tomography in rheumatoid arthritis","volume":"70","author":"Geraldino-Pardilla","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2021.03.008_bib0029","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0140-6736(15)60406-8","article-title":"Evaluation of carotid plaque inflammation in patients with active rheumatoid arthritis using (18)F-fluorodeoxyglucose PET-CT and MRI: a pilot study","volume":"385","author":"Skeoch","year":"2015","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.semarthrit.2021.03.008_bib0030","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/CIRCULATIONAHA.112.120410","article-title":"Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis","volume":"126","author":"Maki-Petaja","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.008_bib0031","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/rheumatology\/kew240","article-title":"Influence of triple disease modifying anti-rheumatic drug therapy on carotid artery inflammation in drug-naive patients with recent onset of rheumatoid arthritis","volume":"55","author":"Haavisto","year":"2016","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.008_bib0032","first-page":"471","article-title":"Performance of Philips Gemini TF PET\/CT scanner with special consideration for its time-of-flight imaging capabilities","volume":"48","author":"Surti","year":"2007","journal-title":"J Nucl Med"},{"issue":"14","key":"10.1016\/j.semarthrit.2021.03.008_bib0033","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1088\/0031-9155\/59\/14\/3843","article-title":"Performance evaluation of the Ingenuity TF PET\/CT scanner with a focus on high count-rate conditions","volume":"59","author":"Kolthammer","year":"2014","journal-title":"Phys Med Biol"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.03.008_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181847","article-title":"Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET\/CT","volume":"12","author":"Lensen","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.008_bib0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-016-1008-z","article-title":"Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study","volume":"18","author":"Bernelot Moens","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.008_bib0036","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/annrheumdis-2016-209176","article-title":"Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy","volume":"75","author":"van der Valk","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.008_bib0037","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2015.03.039","article-title":"The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial","volume":"240","author":"Emami","year":"2015","journal-title":"Atherosclerosis"},{"issue":"14","key":"10.1016\/j.semarthrit.2021.03.008_bib0038","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.clinthera.2010.12.001","volume":"32","author":"Ishii","year":"2010","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.008_bib0039","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jacc.2013.04.066","article-title":"Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography\/computed tomography feasibility study","volume":"62","author":"Tawakol","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2021.03.008_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12947-015-0012-9","article-title":"Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET\/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study)","volume":"13","author":"Watanabe","year":"2015","journal-title":"Cardiovasc Ultrasound"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.008_bib0041","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00259-011-1994-7","article-title":"The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers","volume":"39","author":"Wu","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"19","key":"10.1016\/j.semarthrit.2021.03.008_bib0042","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2015.15629","article-title":"Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the us preventive services task force","volume":"316","author":"Chou","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.008_bib0043","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009217.pub2","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"9313","key":"10.1016\/j.semarthrit.2021.03.008_bib0044","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.008_bib0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.03.008_bib0046","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.semarthrit.2021.03.008_bib0047","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.008_bib0048","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.03.008_bib0049","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.03.008_bib0050","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.008_bib0051","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s12350-017-1121-7","article-title":"(18)F-FDG PET\/CT for the quantification of inflammation in large carotid artery plaques","volume":"26","author":"Johnsrud","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.008_bib0052","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2967\/jnumed.115.154385","article-title":"PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR?","volume":"56","author":"Chen","year":"2015","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.008_bib0053","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jcmg.2016.05.014","article-title":"Defining inflammatory levels of carotid artery and aortic (18)FDG uptake: implications for clinical trial design and individual patient management","volume":"9","author":"Gewirtz","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.008_bib0054","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2967\/jnumed.114.142596","article-title":"Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement","volume":"56","author":"Huet","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semarthrit.2021.03.008_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa789","article-title":"Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis","author":"Agca","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.03.008_bib56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722100038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722100038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:05:12Z","timestamp":1758733512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901722100038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S004901722100038X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.03.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}